ERBB2 and breast cancer: Triple‐negative breast cancer (TNBC), a subtype of breast cancer that is characterized by lack expression of oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), accounting for about 15% of all breast cancers.